JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹16 Cr | ₹17 Cr | ₹20 Cr | ₹17 Cr | ₹17 Cr |
What is the latest Contingent Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹17 Cr |
| Mar2021 | ₹17 Cr |
How is Contingent Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | -0.45 | |
| Mar2024 | ₹17 Cr | -15.25 | |
| Mar2023 | ₹20 Cr | 17.75 | |
| Mar2022 | ₹17 Cr | -0.19 | |
| Mar2021 | ₹17 Cr | - | |
Compare Contingent Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹469.8 Cr | 2.9% | -7.4% | -5.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,991.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,371.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,229.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹108,441.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,407.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | 2.9% |
-7.4% |
-5.1% |
| SENSEX | 2.9% |
-1.1% |
8.5% |
You may also like the below Video Courses